The publisher apologises that the final three pages of this article were missing in its initial publication. This article has been updated to include the pages.
No CrossRef data available.
Article contents
Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology – ERRATUM
Published online by Cambridge University Press: 22 January 2024
Abstract
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
- Type
- Erratum
- Information
- Creative Commons
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.- Copyright
- © The Author(s), 2024. Published by Cambridge University Press
References
Kaski, JP, Kammeraad, JAE, Blom, NA, et al. Indications and management of implantable cardioverter-defibrillator therapy in childhood hypertrophic cardiomyopathy: A position statement from the AEPC Working Group on Basic Science, Genetics and Myocardial Disease and the AEPC Working Group on Cardiac Dysrhythmias and Electrophysiology. Cardiology in the Young. 2023;33(5):681–698. doi: 10.1017/S1047951123000872
CrossRefGoogle Scholar
This correction applies to the following article(s):
Juan Pablo Kaski
[Opens in a new window]Juan Pablo Kaski
, Janneke A.E. Kammeraad
, Nico A. Blom
, Juha-Matti Happonen
, Jan Janousek
[Opens in a new window]Jan Janousek
, Sabine Klaassen
, Giuseppe Limongelli
[Opens in a new window]Giuseppe Limongelli
, Ingegerd Östman-Smith
, Georgia Sarquella Brugada
and Lidia Ziolkowska
You have
Access
Open access